Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or the ‘Company’), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce that it will participate in a Fireside Chat at Canaccord Genuity’s 45th Annual Growth Conference in Boston,…
This week saw tech stocks push the Nasdaq Composite (INDEXNASDAQ:.IXIC) to its best week since June. However, on Monday…
GTI Energy (GTR:AU) has announced Snow Lake Completes Due Diligence and Confirms Placement Download the PDF here. This post…
Lode Gold Resources Inc. (TSXV: LOD,OTC:LODFF) (OTCQB: LODFF) (‘Lode Gold’ or the ‘Company’) is pleased to announce that it…
Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the OTCQB Venture Virtual Investor…
By Darren Brady Nelson One of the underrated, and easily dismissed, stories from the first 100 days of the…
(TheNewswire) Vancouver, British Columbia, August 8th, 2025 TheNewswire Prismo Metals Inc. (‘ Prismo ‘ or the ‘ Company ‘)…